Off-Label Treatment With Immune Checkpoint Inhibitor Blockade

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a phase II therapeutic interventional clinical trial that will evaluate the efficacy, safety, and outcomes of off-label immune checkpoint blockade use across malignancies.
Epistemonikos ID: bd8ddc549f8d985feafdb795dd04200899799589
First added on: Aug 11, 2026